ID	PMID	Mutation	Gene/Protein/Region	Disease	Description	Detail
1	26516904	A8828G	LTR	HTLV-1 Infection Carrier State	S C L	View
2	26516904	C8665T	LTR	HTLV-1 Infection Carrier State	S C L	View
3	26516904	C8718T	LTR	HTLV-1 Infection Carrier State	S C L	View
4	26516904	G8822A	LTR	HTLV-1 Infection Carrier State	S C L	View
5	26516904	T8779C	LTR	HTLV-1 Infection Carrier State	S C L	View
6	26516904	C8367A	LTR	HTLV-1 Infection Carrier State	S C L	View
7	26516904	C8606A	LTR	HTLV-1 Infection Carrier State	S C L	View
8	26516904	C8606G	LTR	HTLV-1 Infection Carrier State	S C L	View
9	26516904	G8295A	LTR	HTLV-1 Infection Carrier State	S C L	View
10	26516904	G8381A	LTR	HTLV-1 Infection Carrier State	S C L	View
11	26516904	G8391A	LTR	HTLV-1 Infection Carrier State	S C L	View
12	26516904	G8392A	LTR	HTLV-1 Infection Carrier State	S C L	View
13	26516904	G8632A	LTR	HTLV-1 Infection Carrier State	S C L	View
14	26516904	G8655T	LTR	HTLV-1 Infection Carrier State	S C L	View
15	26516904	8428_8429 ins A	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
16	26516904	G8446A	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
17	26516904	G8471T	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
18	26516904	C8420T	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
19	26516904	8509_8511 del A	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
20	26516904	A8509G	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
21	26516904	G8545A	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
22	26516904	T8522C	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
23	26516904	T8546C	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View
24	26516904	G8955A	LTR	HTLV-1 Infection Carrier State	S C L	View
25	26516904	T8912C	LTR	HTLV-1 Infection Carrier State	S C L	View
26	26516904	A8403G	LTR;TRE	HTLV-1 Infection Carrier State	S C L	View

Contents
Description

The table shows all curated mutation sites of HTLV1 in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.